AI News
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Lightspeed is in discussions to lead the funding round, sources say.
Read the full story at TechCrunch AITA
TechCrunch AI
Source
TechCrunch AI

AI Analysis
Generated insight by OnAirToday AI
The convergence of AI and drug discovery is accelerating, with established AI researchers like Miles Wang actively building dedicated startups. This signals a significant shift towards AI-driven pharmaceutical innovation with substantial early-stage investment potential.
Powered by AI • Not a substitute for human analysisMore Insights →
Share
Filed under:AI News
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.